Prevention for moderate or severe BPD with intravenous infusion of autologous cord blood mononuclear cells in very preterm infants-a prospective non-randomized placebo-controlled trial and two-year follow up outcomesResearch in context

Prevention for moderate or severe BPD with intravenous infusion of autologous cord blood mononuclear cells in very preterm infants-a prospective non-randomized placebo-controlled trial and two-year follow up outcomesResearch in context

Summary: Background: Bronchopulmonary dysplasia (BPD) is the primary severe complication of preterm birth. Severe BPD was associated with higher risks of mortality, more postnatal growth failure, long term respiratory and neurological developmental retardation. Inflammation plays a central role in...

Full description

Bibliographic Details
Main Authors: Ren Zhuxiao, Xu Fang, Wei Wei, Yang Shumei, Wang Jianlan, Li Qiuping, Pei Jingjun, Nie Chuan, Li Yongsheng, Feng Zhichun, Yang Jie
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:EClinicalMedicine
Subjects:
Bronchopulmonary dysplasia
Very preterm neonates
Autologous cord blood mononuclear cells
Immunomodulation
Outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537023000214

Internet

http://www.sciencedirect.com/science/article/pii/S2589537023000214

Similar Items